Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (1) , 144-151
- https://doi.org/10.1038/bjc.1993.25
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in childrenBritish Journal of Haematology, 2008
- Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.Journal of Clinical Oncology, 1990
- Vascular and interstitial barriers to delivery of therapeutic agents in tumorsCancer and Metastasis Reviews, 1990
- Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitisBritish Journal of Cancer, 1990
- The fallacy of the localized supratentorial malignant gliomaInternational Journal of Radiation Oncology*Biology*Physics, 1988
- A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumorsCancer, 1988
- CORRELATION OF VASCULAR-PERMEABILITY AND BLOOD-FLOW WITH MONOCLONAL-ANTIBODY UPTAKE BY HUMAN CLOUSER AND RENAL-CELL XENOGRAFTS1988
- Is There a Role for Radioimmunolocalization in Diagnosis of Intracranial Malignancies?: Discussion PaperJournal of the Royal Society of Medicine, 1984
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978